{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-115745","form_type":"8-K","ticker":"MXCT","cik":"0001287098","company_name":"MAXCYTE, INC.","filed_at":"2026-10-14T12:10:32+00:00","discovered_at":"2026-10-14T12:15:00.266835+00:00","generated_at":"2026-10-14T12:15:05.983333+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MaxCyte preliminary Q3 core revenue ~$8.1M, up 26% YoY; raises FY2026 revenue guidance to ~$34M","bullets":["Q3 2026 preliminary core business revenue ~$8.1M, up 26% YoY; SPL Program-related revenue over $1.0M, including a $1.0M milestone received in Q3.","FY2026 revenue guidance raised to ~$34M from prior $30M-$32M: core business ~$28M (prior $25M-$27M) and SPL Program ~$6M (prior ~$5M).","SPL guidance includes ~$4M of milestone payments and ~$2M of commercial royalties; this was MaxCyte's second SPL milestone of 2026.","CEO Maher Masoud cites accelerated instrument purchasing from a large customer pulled forward from Q4; core business up ~15% YoY in H2 2026.","Royalty revenue and full results due Nov 10, 2026; two SPL-partner pivotal trials have potential approval as early as next year."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-115745","json":"https://secwatch.observer/filing/0001104659-26-115745.json","markdown":"https://secwatch.observer/filing/0001104659-26-115745.md","text":"https://secwatch.observer/filing/0001104659-26-115745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287098/000110465926115745/0001104659-26-115745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287098/000110465926115745/tm2627568d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T12:15:05.983333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}